IP Library Granted Patent US 7,544,828
Granted Patent B2
US 7,544,828 · App. 11/582,716 · Granted Jun 9, 2009

Process for preparation of Bicalutamide

Assignee: Dabur Pharma Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,544,828
App. No.
11/582,716
Granted
Jun 9, 2009
Kind
B2
Abstract

A process for preparation of Bicalutamide of formula (I), comprising oxidation of compound of formula (II), with potassium permanganate in presence of water or a mixture of water and water miscible solvent and isolating Bicalutamide of formula (I) thereof.

Claims (31)

1. A process for preparation of Bicalutamide of formula (I),

comprising:

oxidizing of compound of formula (II),

with potassium permanganate in presence of water or with potassium permanganate in the presence of a mixture of water and water miscible solvent; and

isolating Bicalutamide of formula (I).

2. A process according to claim 1 , wherein oxidizing is carried out at a temperature of 25-60° C.

3. A process according to claim 1 , wherein oxidizing is carried out at a temperature of 25-45° C.

4. A process according to claim 1 , wherein the water miscible solvent is selected from a nitrile, a ketone and an aliphatic acid.

5. A process according to claim 4 , wherein the nitrile is selected from acetonitrile, propionitrile and benzonitrile.

6. A process according to claim 4 , wherein the ketone is selected from acetone, methyl isobutyl ketone, methyl ethyl ketone and cyclohexanone.

7. A process according to claim 4 , wherein the aliphatic acid is selected from acetic acid, propionic acid and butyric acid.

8. A process according to claim 1 , wherein the water miscible organic solvent comprises acetonitrile.

9. A process according to claim 1 , wherein the water miscible organic solvent comprises acetone.

10. A process according to claim 1 , wherein the water miscible organic solvent comprises acetic acid.

11. A process according to claim 1 , wherein the ratio of water to the water miscible organic solvent is between 1:1 and 1:4.

12. A process according to claim 1 , wherein the ratio of water to the water miscible organic solvent is between 1:1 and 1:2.

13. A process according to claim 1 , wherein potassium permanganate is in molar proportions of 1 to 3 equivalent per mole of compound of formula (II).

14. A process according to claim 1 , wherein potassium permanganate is in molar proportions of 2 to 3 equivalent per mole of compound of formula (II).

15. A process according to claim 1 , wherein isolated Bicalutamide of formula (I) employs acetonitrile.

16. A process according to claim 15 , further comprising crystallizing Bicalutamide of formula (I) from a mixture of ethyl acetate and petroleum ether.

17. A process for preparation of Bicalutamide of formula (I)

comprising:

oxidizing a compound of formula (II),

with potassium permanganate in the presence of water or with potassium permanganate in the presence of a mixture of water and water miscible solvent; wherein the water miscible solvent comprises acetonitrile, propionitrile, benzonitrile, acetone, methyl isobutyl ketone, methyl ethyl ketone, cyclohexanone, acetic acid, propionic acid, or butyric acid; and

isolating Bicalutamide of formula (I).

18. The process of claim 17 , wherein the water miscible organic solvent comprises acetonitrile, acetone, or acetic acid.

19. The process of claim 18 , wherein the water miscible organic solvent comprises acetonitrile.

20. The process of claim 17 , wherein the ratio of water to the water miscible organic solvent is 1:1 to 1:4.

21. The process of claim 17 , wherein potassium permanganate is in molar proportions of 1 to 3 equivalent per mole of compound of formula (II).

22. The process of claim 17 , wherein isolating employs acetonitrile.

23. The process of claim 22 , further comprising crystallizing Bicalutamide of formula (I) from a mixture of ethyl acetate and petroleum ether.

Assignments (2)
CHANGE OF NAME Recorded Dec 8, 2009
From: DABUR PHARMA LIMITED
To: FRESENIUS KABI ONCOLOGY LIMITED
Reel/Frame 023621/0023 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2006
From: SHUKLA, ANIL KUMAR; MAIKAP, GOLAK CHANDRA; AGARWAL, SHIV KUMAR
To: DABUR PHARMA LIMITED
Reel/Frame 018440/0767 →
Priority Claims (1)
IN 1187/2005 · Dec 27, 2005 · national
Continuity (1)
Related Publication 20070149800A1 · Jun 28, 2007